{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:13:59Z","timestamp":1784542439735,"version":"3.55.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00277-024-05935-1","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T09:02:18Z","timestamp":1723539738000},"page":"6027-6030","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of a plerixafor sparing mobilization regimen for autologous hematopoietic cell transplant in multiple myeloma"],"prefix":"10.1007","volume":"103","author":[{"given":"Daniel","family":"Cancilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Paul","family":"Nurse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Cenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Matia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Coffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty K.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Khouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"issue":"19","key":"5935_CR1","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"JA Child","year":"2003","unstructured":"Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, Brown J, Drayson MT, Selby PJ, Medical Research Council Adult Leukaemia Working Party (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348(19):1875\u20131883. https:\/\/doi.org\/10.1056\/NEJMoa022340","journal-title":"N Engl J Med"},{"issue":"3","key":"5935_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4103\/tcmj.tcmj_98_21","volume":"34","author":"HH Chang","year":"2021","unstructured":"Chang HH, Liou YS, Sun DS (2021) Hematopoietic stem cell mobilization. Tzu Chi Med J 34(3):270\u2013275. https:\/\/doi.org\/10.4103\/tcmj.tcmj_98_21","journal-title":"Tzu Chi Med J"},{"issue":"2","key":"5935_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/ijlh.13142","volume":"42","author":"JR Furundarena","year":"2020","unstructured":"Furundarena JR, Uranga A, Alkorta A, Gonz\u00e1lez C, Ferreiro J, Rey J, Arag\u00f3n M, Urreta L, Emparanza I, Red\u00edn JI, Garrido H, A., Araiz M (2020) Evaluation of the predictive value of the hematopoietic progenitor cell count using an automated hematology analyzer for CD34\u2009+\u2009stem cell mobilization and apheresis product yield. Int J Lab Hematol 42(2):170\u2013179. https:\/\/doi.org\/10.1111\/ijlh.13142","journal-title":"Int J Lab Hematol"},{"key":"5935_CR4","doi-asserted-by":"publisher","unstructured":"DiPersio JF, Stadtmauer EA, Nademanee A, Micallef IN, Stiff PJ, Kaufman JL, Maziarz RT, Hosing C, Fr\u00fcehauf S, Horwitz M, Cooper D, Bridger G, Calandra G (3102) & Investigators (2009). Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. Blood, 113(23), 5720\u20135726. https:\/\/doi.org\/10.1182\/blood-2008-08-174946","DOI":"10.1182\/blood-2008-08-174946"},{"issue":"8","key":"5935_CR5","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1080\/10428194.2016.1271946","volume":"58","author":"C Greil","year":"2017","unstructured":"Greil C, Kiote-Schmidt C, Fink G, Ihorst G, Hildenbeutel S, Bosse R, Duyster J, Engelhardt M, W\u00e4sch R (2017) Successful peripheral blood stem cell mobilization with a cost-efficient single fixed-dose plerixafor schedule in poor mobilizers. Leuk Lymphoma 58(8):1849\u20131858. https:\/\/doi.org\/10.1080\/10428194.2016.1271946","journal-title":"Leuk Lymphoma"},{"key":"5935_CR6","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1080\/10428194.2017.1393673","volume":"59","author":"C Greil","year":"2018","unstructured":"Greil C, Ihorst G, Kiote-Schmidt C, Hildenbeutel S, K\u00fchbach K, Bosse R, Duyster J, Engelhardt M, W\u00e4sch R (2018) Stem cell mobilization in poor mobilizers with multiple myeloma or lymphoma before and after introduction of plerixafor: a single center comparative analysis using a cost-efficient single fixed-dose schedule. Leuk Lymphoma 59:1722\u20131725","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"5935_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/jca.21892","volume":"36","author":"SR Sanikommu","year":"2021","unstructured":"Sanikommu SR, Reese ES, He J, Lee C, Ai J, Butler CM, Jacobs R, Hu B, Atrash S, Trivedi J, Bhutani M, Voorhees P, Usmani SZ, Ghosh N, Fasan O, Druhan LJ, Symanowski J, Copelan EA, Avalos BR (2021) Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation. J Clin Apheresis 36(4):553\u2013562. https:\/\/doi.org\/10.1002\/jca.21892","journal-title":"J Clin Apheresis"},{"key":"5935_CR8","doi-asserted-by":"publisher","unstructured":"Shah EE, Young RP, Wong SW, Damon LE, Wolf JL, Shah ND, Leavitt AD, Loeffler P, Martin TG 3rd (2020) Impact of Plerixafor Use at different peripheral blood CD34\u2009+\u2009thresholds on autologous stem cell Collection in patients with multiple myeloma. Biology of blood and marrow transplantation: journal of the American Society for Blood and marrow transplantation. 26(5):876\u2013883. https:\/\/doi.org\/10.1016\/j.bbmt.2019.11.024","DOI":"10.1016\/j.bbmt.2019.11.024"},{"issue":"6","key":"5935_CR9","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/sj.leu.2405035","volume":"22","author":"A Mazumder","year":"2008","unstructured":"Mazumder A, Kaufman J, Niesvizky R, Lonial S, Vesole D, Jagannath S (2008) Effect of lenalidomide therapy on mobilization of peripheral blood stem cells in previously untreated multiple myeloma patients. Leukemia 22(6):1280\u20131282. https:\/\/doi.org\/10.1038\/sj.leu.2405035","journal-title":"Leukemia"},{"issue":"4","key":"5935_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2450\/BloodTransfus.667","volume":"22","author":"A Zappaterra","year":"2024","unstructured":"Zappaterra A, Civettini I, Cafro AM, Pezzetti L, Pierini S, Anghilieri M, Bellio L, Bertazzoni P, Grillo G, Minga P, Pioltelli ML, Ravano E, Sassone M, Vigan\u00f2 CV, Volpato EB, Gambacorti-Passerini C, Rossini S, Cairoli R, Crocchiolo R (2024) Anti-CD38 monoclonal antibody impairs CD34\u2009+\u2009mobilization and affects clonogenic potential in multiple myeloma patients. Blood Transfus 22(4):328\u2013337. https:\/\/doi.org\/10.2450\/BloodTransfus.667","journal-title":"Blood Transfus"},{"key":"5935_CR11","doi-asserted-by":"publisher","unstructured":"Young EE, Wong RP, Damon SW, Wolf LE, Shah JL, Leavitt ND, Loeffler AD, P., Martin TG 3rd (2020) Impact of Plerixafor Use at different peripheral blood CD34\u2009+\u2009thresholds on autologous stem cell Collection in patients with multiple myeloma. Biology Blood Marrow Transplantation: J Am Soc Blood Marrow Transplantation 26(5):876\u2013883. https:\/\/doi.org\/10.1016\/j.bbmt.2019.11.024","DOI":"10.1016\/j.bbmt.2019.11.024"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05935-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05935-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05935-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:07:12Z","timestamp":1735866432000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05935-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5935"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05935-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of Cleveland Clinic approved this study. Informed consent, whenever applicable, was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}